Bone Changes After Switching Osteoporosis Treatment
Author Information
Author(s): Jobke Björn, Burghardt Andrew J., Muche Burkhard, Hahn Michael, Semler Jutta, Amling Michael, Majumdar Sharmila, Busse Björn
Primary Institution: University Medical Center Hamburg-Eppendorf
Hypothesis
What are the effects of switching from bisphosphonate to strontium ranelate on bone microstructure and mineralization in an osteoporotic patient?
Conclusion
Switching to strontium ranelate after bisphosphonate treatment significantly increased bone volume fraction and improved trabecular architecture.
Supporting Evidence
- Bone volume fraction increased significantly after one year of strontium ranelate treatment.
- Trabecular architecture changed from rod-like to plate-like structures.
- Mineralization profile was maintained despite strontium deposition on bone surfaces.
- Clinical markers indicated stimulated bone formation after switching treatments.
Takeaway
This study looked at one woman's bones over six years and found that changing her osteoporosis medicine helped her bones get stronger.
Methodology
Five bone biopsies were taken from the iliac crest of a 75-year-old woman over six years, analyzing changes in bone structure and mineralization after switching treatments.
Limitations
The study is limited to one individual and may not represent broader populations; also, the biopsies may overlap in regions.
Participant Demographics
One postmenopausal female patient, 75 years old, with multiple vertebral fractures.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website